reglab/housing_qa huggingface dataset:
NJ Rev Stat § 26:5C-11 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:5C-11 - Disclosed record to be held confidential by recipient

26:5C-11. Disclosed record to be held confidential by recipient  Any record disclosed under this act shall be held confidential by the recipient of the record and shall not be released by said recipient unless the conditions of this act are met.  L.1989, c.303, s.7.
NJ Rev Stat § 26:5C-12 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:5C-12 - Consent to disclose record of deceased, legally incapacitated person.

26:5C-12 Consent to disclose record of deceased, legally incapacitated person.  8. When consent is required for disclosure of the record of a deceased or legally incapacitated person who has or is suspected of having AIDS or HIV infection, consent may be obtained: a. From an executor, administrator of the estate, or authorized representative of the legally incapacitated or deceased person; b. From the person's spouse, domestic partner as defined in section 3 of P.L.2003, c.246 (C.26:8A-3), primary caretaking partner or, if none, by another member of the person's family; and c. From the commissioner in the event that a deceased person has neither an authorized representative or next-of-kin. L.1989, c.303, s.8; amended 2003, c.246, s.30; 2013, c.103, s.74.
NJ Rev Stat § 26:5C-13 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:5C-13 - Consent for disclosure of minor's record

26:5C-13. Consent for disclosure of minor's record  When consent is required for disclosure of the record of a minor who has or is suspected of having AIDS or HIV infection, consent shall be obtained from the parent, guardian, or other individual authorized under State law to act in the minor's behalf.  L.1989, c.303, s.9.
NJ Rev Stat § 26:5C-14 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:5C-14 - Civil actions permitted against violators

26:5C-14. Civil actions permitted against violators  a. A person who has or is suspected of having AIDS or HIV infection who is aggrieved as a result of a violation of this act may commence a civil action against the individual or institution who committed the violation to obtain appropriate relief, including actual damages, equitable relief and reasonable attorney's fees and court costs. Punitive damages may be awarded when the violation evidences wantonly reckless or intentionally malicious conduct by the person or institution who committed the violation.  b. Each disclosure made in violation of this act is a separate and actionable offense. L.1989, c.303, s.10.
NJ Rev Stat § 26:5C-15 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:5C-15 - Definitions.

26:5C-15 Definitions.  1. As used in this act: "AIDS" means acquired immune deficiency syndrome as defined by the Centers for Disease Control and Prevention of the United States Public Health Service. "Commissioner" means the Commissioner of Health. "Department" means the Department of Health. "HIV" means the human immunodeficiency virus or any other related virus identified as a probable causative agent of AIDS. L.1995, c.174, s.1; amended 2007, c.218, s.1; 2012, c.17, s.342.
NJ Rev Stat § 26:5C-16 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:5C-16 - Policy statement; information on HIV testing; guidelines for notification; confidentiality.

26:5C-16 Policy statement; information on HIV testing; guidelines for notification; confidentiality.  2. It is the policy of this State that: testing of all pregnant women for HIV shall be part of routine prenatal care; and, in the absence of a specific objection to the testing by the pregnant woman, all pregnant women shall be tested for HIV as early as possible in their pregnancy, and again during the third trimester of their pregnancy; testing of all pregnant women for HIV shall be voluntary and free of coercion; and a pregnant woman shall not be denied testing for HIV on the basis of her economic status.  a. (1) A physician or other health care practitioner who is the primary caregiver for a pregnant woman shall, in accordance with guidelines developed by the commissioner, provide the woman with information about HIV and AIDS, including an explanation of HIV infection and the meanings of positive and negative test results, and also inform the woman of the benefits of being tested for HIV as early as possible in the course of her pregnancy and a second time during the third trimester, the medical treatment available to treat HIV infection if diagnosed early, the reduced rate of transmission of HIV to a fetus if an HIV-infected pregnant woman receives treatment for HIV, and the interventions that are available to reduce the risk of transmission of HIV to the fetus and newborn. The information shall be provided orally or in writing, and the woman shall be offered an opportunity to ask questions. The physician or other health care practitioner shall also advise the woman that HIV testing is recommended for all pregnant women both early in their pregnancy and during the third trimester, and that she will receive HIV tests as part of the routine panel of prenatal tests unless she specifically declines to be tested for HIV.  If a woman declines to be tested for HIV, the declination shall be documented in her medical record. A woman shall not be denied appropriate prenatal or other medical care because she declines to be tested for HIV. (2) A pregnant woman, who presents herself for delivery and has not been tested for HIV during the course of her pregnancy, shall be given the information specified in paragraph (1) of this subsection as soon as may be medically appropriate and, unless she declines to be tested for HIV after receiving that information, shall be tested for HIV as soon as may be medically appropriate. b. The commissioner shall establish guidelines regarding notification to a woman whose test result is positive, and to provide, to the maximum extent possible, for counseling about the significance of the test result. c. Information about a woman which is obtained pursuant to this section shall be held confidential in accordance with the provisions of P.L.1989, c.303 (C.26:5C-5 et seq.). L.1995,c.174,s.2; amended 2007, c.218, s.2.
NJ Rev Stat § 26:5C-17 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:5C-17 - Fees

26:5C-17. Fees  3. If a test sample taken pursuant to section 2 of this act is analyzed in the department's laboratory, the department may charge a reasonable fee for the test. The amount of the fee and the procedures for collecting the fee shall be established by the commissioner.  L.1995,c.174,s.3.
NJ Rev Stat § 26:5C-18 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:5C-18 - Action due to unauthorized disclosure

26:5C-18. Action due to unauthorized disclosure  4. A woman who has or is suspected of having AIDS or HIV infection may pursue an action against a person who makes an unauthorized disclosure of any information concerning the woman's positive test result for the presence of antibodies to HIV which is obtained pursuant to section 2 of this act, in accordance with the provisions of section 10 of P.L.1989, c.303 (C.26:5C-14).  L.1995,c.174,s.4.
NJ Rev Stat § 26:5C-19 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:5C-19 - Agreements authorized

26:5C-19. Agreements authorized  5. The commissioner is authorized to enter into agreements with the federal government and public health agencies in other states to achieve greater effectiveness or efficiency in carrying out the provisions of this act.  L.1995,c.174,s.5.
NJ Rev Stat § 26:5C-20 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:5C-20 - Rules, regulations.

26:5C-20 Rules, regulations.  6. The commissioner, pursuant to the "Administrative Procedure Act," P.L.1968, c.410 (C.52:14B-1 et seq.), shall adopt rules and regulations to effect this act. The regulations shall be consistent with the latest recommendations for HIV testing of pregnant women prepared by the United States Centers for Disease Control and Prevention. L.1995,c.174,s.6; amended 2007, c.218, s.3.
NJ Rev Stat § 26:5C-21 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:5C-21 - Definitions relative to HIV testing by semen banks.

26:5C-21 Definitions relative to HIV testing by semen banks.  1. As used in this act: "HIV" means the human immunodeficiency virus which has been identified as the probable causative agent of acquired immune deficiency syndrome, or AIDS. "HIV test" means a laboratory test designed to detect the presence of HIV, its related antigens, or antibodies to HIV. "Semen bank" means a commercial or noncommercial activity involving the handling of human semen which participates in the collection, processing, storage or distribution of semen. L.1997,c.246,s.1.
NJ Rev Stat § 26:5C-22 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:5C-22 - HIV test on potential semen donor; consent; payment; notification.

26:5C-22 HIV test on potential semen donor; consent; payment; notification.  2. a. A semen bank shall perform an HIV test on a potential donor prior to that person donating semen and shall freeze all donated semen for a waiting period of at least six months, in accordance with standards adopted by the United States Centers for Disease Control and Prevention. b. A semen bank shall perform the HIV test only after the donor has provided written informed consent according to standards adopted by the Commissioner of Health. A donor who refuses to provide written informed consent to an HIV test or tests positive for HIV shall not be permitted to donate semen. c. The cost of the HIV test shall be borne by the recipient of the donation. d. The Commissioner of Health shall establish procedures for notification by a semen bank to donors of screening results and referrals to appropriate counseling and health care services as necessary. L.1997, c.246, s.2; amended 2012, c.17, s.343.
NJ Rev Stat § 26:5C-23 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:5C-23 - Violations, penalty.

26:5C-23 Violations, penalty.  3. A semen bank which violates any provision of this act is guilty of a disorderly persons offense and is liable to a penalty of not more than $1,000 for each offense. L.1997,c.246,s.3.
NJ Rev Stat § 26:5C-24 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:5C-24 - Rules, regulations.

26:5C-24 Rules, regulations.  4. The Commissioner of Health, pursuant to the "Administrative Procedure Act," P.L.1968, c.410 (C.52:14B-1 et seq.), shall adopt rules and regulations to effectuate the purposes of this act. L.1997, c.246, s.4; amended 2012, c.17, s.344.
NJ Rev Stat § 26:5C-25 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:5C-25 - Short title.

26:5C-25 Short title.  1. This act shall be known and may be cited as the "Bloodborne Disease Harm Reduction Act." L.2006, c.99, s.1.
NJ Rev Stat § 26:5C-26 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:5C-26 - Findings, declarations relative to sterile syringe access programs.

26:5C-26 Findings, declarations relative to sterile syringe access programs.  2. The Legislature finds and declares that: a. Injection drug use is one of the most common methods of transmission of HIV, hepatitis C, and other bloodborne pathogens; b. About one in every three persons living with HIV or AIDS is female; c. More than a million people in the United States are frequent intravenous drug users at a cost to society in health care, lost productivity, accidents, and crime of more than $50 billion annually; d. Sterile syringe access programs have been proven effective in reducing the spread of HIV, hepatitis C, and other bloodborne pathogens without increasing drug abuse or other adverse social impacts;  e. Every scientific, medical, and professional agency or organization that has studied this issue, including the federal Centers for Disease Control and Prevention, the American Medical Association, the American Public Health Association, the National Academy of Sciences, the National Institutes of Health Consensus Panel, the American Academy of Pediatrics, and the United States Conference of Mayors, has found sterile syringe access programs to be effective in reducing the transmission of HIV; and f. Sterile syringe access programs are designed to prevent the spread of HIV, hepatitis C, and other bloodborne pathogens, and to provide a bridge to drug abuse treatment and other social services for drug users; and it is in the public interest to establish such programs in this State in accordance with statutory guidelines designed to ensure the safety of consumers who use these programs, the health care workers who operate them, and the members of the general public. L.2006, c.99, s.2; amended 2016, c.36, s.1.
NJ Rev Stat § 26:5C-29 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:5C-29 - Reports to Governor, Legislature.

26:5C-29 Reports to Governor, Legislature.  5. a. (1) The Commissioner of Health shall report to the Governor and, pursuant to section 2 of P.L.1991, 164 (C.52:14-19.1), the Legislature, no later than one year after the effective date of P.L.2006, c.99 (C.26:5C-25 et seq.) and biennially thereafter, on the status of sterile syringe access programs established pursuant to sections 3 and 4 of P.L.2006, c.99 (C.26:5C-27 and C.26:5C-28), as amended by P.L.2016, c.36, and shall include in that report the data provided to the commissioner by each sterile syringe access program pursuant to paragraph (11) of subsection b. of section 4 of P.L.2006, c.99 (C.26:5C-28), as amended by P.L.2016, c.36. (2) For the purpose of each biennial report pursuant to paragraph (1) of this subsection, the commissioner shall: (a) consult with local law enforcement authorities regarding the impact of the sterile syringe access programs on the rate and volume of crime in the affected municipalities and include that information in the report; and (b) seek to obtain data from public safety and emergency medical services providers Statewide regarding the incidence and location of needle stick injuries to their personnel and include that information in the report. b. (Deleted by amendment, P.L.2016, c.36) c. The commissioner shall prepare a detailed analysis of the sterile syringe access programs, and report on the results of that analysis to the Governor, the Governor's Advisory Council on HIV/AIDS and Related Blood-Borne Pathogens, and, pursuant to section 2 of P.L.1991, c.164 (C.52:14-19.1), the Legislature annually. The analysis shall include, but not be limited to: (1) any increase or decrease in the spread of HIV, hepatitis C and other bloodborne pathogens that may be transmitted by the use of contaminated syringes and needles; (2) the number of exchanged syringes and needles and an evaluation of the disposal of syringes and needles that are not returned by consumers; (3) the number of consumers participating in the sterile syringe access programs and an assessment of their reasons for participating in the programs; (4) the number of consumers in the sterile syringe access programs who participated in substance use disorder treatment programs; and (5) the number of consumers in the sterile syringe access programs who benefited from counseling and referrals to programs and entities that are relevant to their health, housing, social service, employment and other needs. d. (Deleted by amendment, P.L.2016, c.36) L.2006, c.99, s.5; amended 2015, c.10, s.6; 2016, c.36, s.3; 2017, c.131, s.105.
NJ Rev Stat § 26:5C-30 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:5C-30 - Plan for establishment, funding of regional substance abuse treatment facilities.

26:5C-30 Plan for establishment, funding of regional substance abuse treatment facilities.  6. a. The Commissioner of Human Services shall develop a plan for establishing and funding regional substance abuse treatment facilities. The plan shall include a strategy for soliciting proposals from nonprofit agencies and organizations in the State, including State-licensed health care facilities, with experience in the provision of long-term care or outpatient substance abuse treatment services to meet the post-acute health, social, and educational needs of persons living with HIV/AIDS. b. The commissioner shall submit the plan to the Governor and, pursuant to section 2 of P.L.1991, c.164 (C.52:14-19.1), the Legislature no later than the 120th day after the effective date of this act, and shall report biannually thereafter to the Governor and, pursuant to section 2 of P.L.1991, c.164 (C.52:14-19.1), the Legislature on the implementation of the plan. L.2006, c.99, s.6.
NJ Rev Stat § 26:5C-31 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:5C-31 - Rules, regulations.

26:5C-31 Rules, regulations.  7. a. The Commissioner of Health and Senior Services, in consultation with the Commissioner of Environmental Protection and pursuant to the "Administrative Procedure Act," P.L.1968, c.410 (C.52:14B-1 et seq.), shall adopt rules and regulations to effectuate the purposes of sections 3 and 4 of P.L.2006, c.99 (C.26:5C-27 and C.26:5C-28). b. Notwithstanding any provision of P.L.1968, c.410 to the contrary, the commissioner shall adopt, immediately upon filing with the Office of Administrative Law and no later than the 90th day after the effective date of this act, such regulations as the commissioner deems necessary to implement the provisions of sections 3 and 4 of P.L.2006, c.99 (C.26:5C-27 and C.26:5C-28), which shall be effective until the adoption of rules and regulations pursuant to subsection a. of this section and may be amended, adopted or readopted by the commissioner in accordance with the requirements of P.L.1968, c.410. L.2006, c.99, s.7.
NJ Rev Stat § 26:5D-1 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:5D-1 - Short title

26:5D-1. Short title  This act shall be known and may be cited as the "SIDS Assistance Act."  L. 1987,c.331, s.1.
NJ Rev Stat § 26:5D-2 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:5D-2 - Findings, declarations

26:5D-2. Findings, declarations  The Legislature finds and declares that:  a. Sudden Infant Death Syndrome, the sudden and unexpected death of apparently healthy babies, commonly known as "SIDS" or "Crib Death," is the major cause of death of infants between the ages of one month and one year and is responsible for the deaths of approximately 7,000 infants in the United States each year.  b. Although the cause of SIDS is not known, there is evidence that it may be caused by an infectious agent, hypoglycemia, a neuroendocrine defect, or poor socioeconomic conditions. SIDS has also been associated with apnea, the temporary stoppage of breathing; however, there are no data firmly linking SIDS to apnea, and preliminary data suggest that the number of infants who have had a history of apneic episodes may account for not more than 5% of SIDS fatalities.  c. Because of the nature of SIDS and the inability to discover the cause of death, parents of victims of SIDS often experience trauma and shock and have a need for counseling and other support services.  d. Research regarding the detection, treatment, cure or prevention of SIDS has not been afforded the attention given to other areas of medicine, and many health care professionals are not familiar with the symptoms, diagnosis or treatment of SIDS; and  e. Therefore, it is imperative that a program be established for identifying and treating infants who are potential victims of SIDS, referring potential SIDS victims and their families to sources of treatment and counseling, referring families whose children have been victims of SIDS to counseling and other support services and providing an educational program to health care professionals to heighten their awareness in detecting potential SIDS victims and in preventing SIDS.  L. 1987,c.331, s.2.
NJ Rev Stat § 26:5D-3 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:5D-3 - Referral service; hotline

26:5D-3. Referral service; hotline  The Commissioner of the Department of Health shall establish a program to educate the public and health care professionals about SIDS. The program shall include a referral service for the public and health care professionals on SIDS related services and a 24-hour telephone hotline to provide needed information and referrals. The commissioner shall also encourage the development of local support programs to provide early detection, counseling, and referrals for infants who may be at risk of SIDS.  L. 1987,c.331, s.3.
NJ Rev Stat § 26:5D-4 (2021)
2021 New Jersey Revised Statutes|Title 26 - Health and Vital Statistics|Section 26:5D-4 - SIDS Resource Center

26:5D-4. SIDS Resource Center  The Commissioner of the Department of Health shall establish a "SIDS Resource Center" within a State medical school. The SIDS Resource Center shall, in coordination with the Department of Health, serve as a technical advisory center and may offer diagnostic procedures, medical treatment and counseling, as well as any other services that may be necessary to assist potential SIDS victims and their families.  L. 1987,c.331, s.4.